How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments Fulgent Genetics enters this update cycle with no changes to its price targets, leaving the existing analyst expectations intact for…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Fulgent Genetics: Erhöhte Prognose und starke Studienergebnisse treiben Aktie auf 12-Monatshoch Nach einem damaligen Rekordumsatz von 32,5 Mio. USD im Jahr 2019 steigerte Fulgent seine Umsätze in den Corona-Jahren 2020 und…
Fulgent Genetics soars 65% after InvestingPro’s January Fair Value alert By Investing.com Fulgent Genetics soars 65% after InvestingPro’s January Fair Value alert…
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 96.97% and 1.90%, respectively, for the quarter ended March 2024. Do…